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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
Nutriose
®
06 and a reduction of post-prandial glycaemic responses pursuant 
to Article 13(5) of Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Roquette Italia S.P.A., submitted for authorisation of a health claim pursuant to 
Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the EFSA Panel on 
Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation 
of a health claim related to Nutriose
®
06 and a reduction of post-prandial glycaemic responses. Non-digestible 
carbohydrates, including resistant dextrin in Nutriose
®
06, are resistant to hydrolysis and absorption in the small 
intestine and therefore do not contribute to post-prandial glycaemia. This opinion applies to non-digestible 
carbohydrates (e.g. non-starch polysaccharides, resistant oligosaccharides and resistant starch), which should 
replace glycaemic carbohydrates in foods or beverages in order to obtain the claimed effect. The Panel considers 
that the food constituent, non-digestible carbohydrates, which is the subject of the health claim, and the food 
constituent (i.e. glycaemic carbohydrates) that non-digestible carbohydrates should replace in foods or beverages 
are both sufficiently characterised in relation to the claimed effect. The Panel considers that a reduction of post-
prandial glycaemic responses might be a beneficial physiological effect. A claim on non-digestible carbohydrates 
and reduction of post-prandial glycaemic responses has already been assessed by the Panel with a favourable 
outcome. The previous evaluation, including the proposed wording and the conditions of use, also applies to this 
application. The Panel concludes that a cause and effect relationship has been established between the 
consumption of foods/beverages containing non-digestible carbohydrates and a reduction of post-prandial 
glycaemic responses as compared with foods/beverages containing glycaemic carbohydrates. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following an application from Roquette Italia S.P.A., submitted for authorisation of a health claim 
pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on 
the scientific substantiation of a health claim related to Nutriose
®
06 and a reduction of post-prandial 
glycaemic responses. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. The application included a request for the protection of proprietary data. 
The food that is the subject of the health claim is resistant dextrin in Nutriose
®
06, which should 
replace glycaemic carbohydrates in foods or beverages in order to obtain the claimed effect (i.e. 
reduction of post-prandial glycaemic responses). The Panel notes that the characteristic which is most 
relevant to the claimed effect is not unique to resistant dextrin but is common to other non-digestible 
carbohydrates (e.g. non-starch polysaccharides and resistant oligosaccharides) because, similar to 
resistant dextrin, non-digestible carbohydrates are resistant to hydrolysis and absorption in the small 
intestine and therefore do not contribute to post-prandial glycaemia. This opinion applies to non-
digestible carbohydrates (e.g. non-starch polysaccharides, resistant oligosaccharides and resistant 
starch), which should replace glycaemic carbohydrates in foods or beverages in order to obtain the 
claimed effect. The Panel considers that the food constituent, non-digestible carbohydrates, which is 
the subject of the health claim, and the food constituent (i.e. glycaemic carbohydrates) that non-
digestible carbohydrates should replace in foods or beverages are both sufficiently characterised in 
relation to the claimed effect. 
The claimed effect proposed by the applicant relates to the reduction of post-prandial blood glucose 
responses. The target population proposed by the applicant is individuals wishing to reduce their post-
prandial glycaemic responses. The Panel considers that a reduction of post-prandial glycaemic 
responses (as long as post-prandial insulinaemic responses are not disproportionately increased) might 
be a beneficial physiological effect. 
The applicant submitted six unpublished human studies as being pertinent to the health claim. 
A claim on non-digestible carbohydrates and reduction of post-prandial glycaemic responses has 
already been assessed by the Panel with a favourable outcome. 
The Panel considers that the previous evaluation on the replacement of sugars with non-digestible 
carbohydrates applies to the replacement of all glycaemic carbohydrates with non-digestible 
carbohydrates, including the proposed wording and the conditions of use. 
The Panel concludes that a cause and effect relationship has been established between the 
consumption of foods/beverages containing non-digestible carbohydrates and a reduction of post-
prandial glycaemic responses as compared with foods/beverages containing glycaemic carbohydrates. 
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BACKGROUND 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation, and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health) which are based on newly developed 
scientific evidence, or which include a request for the protection of proprietary data, to the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted claims referred to in Article 13(3) shall be submitted by the applicant to the national 
competent authority of a Member State, which will make the application and any supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
 The application was received on 03/02/2014. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence. The application included a request for the protection of 
proprietary data. 
 The scientific evaluation procedure started on 24/03/2014. 
 On 07/05/2014, the Working Group on Claims of the NDA Panel agreed on a list of questions 
for the applicant to provide additional information to accompany the application, and the 
clock was stopped on 19/05/2014, in compliance with Article 18(3) of Regulation (EC) 
No 1924/2006. 
 On 27/05/2014, EFSA received the requested information and the clock was restarted, in 
compliance with Article 18(3) of Regulation (EC) No 1924/2006. 
 During its meeting on 18/09/2014, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to non-digestible 
carbohydrates and a reduction of post-prandial glycaemic responses. 
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: non-digestible carbohydrates 
(including resistant dextrin in Nutriose
®
06) and a reduction of post-prandial glycaemic responses. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the 
marketing of non-digestible carbohydrates, a positive assessment of their safety, nor a decision on 
whether non-digestible carbohydrates are, or are not, classified as a foodstuff. It should be noted that 
such an assessment is not foreseen in the framework of Regulation (EC) No 1924/2006. 
                                                     
4 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. 
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It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
Nutriose
®
06 and reduction of post-prandial glycaemic responses 
 
 
EFSA Journal 2014;12(10):3839 6 
INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Roquette Italia S.P.A., Via Serravalle 26, 15063 Cassano Spinola, 
Alessandria, Italy. 
The application includes a request for the protection of proprietary data for six unpublished studies 
(Donazzolo and Latreille-Barbier, 2000; GI labs, 2007; Thondre and Lightowler, 2012; Yuexin et al., 
2012; Gendre, 2013; Salvi, 2013), in accordance with Article 21 of Regulation (EC) No 1924/2006. 
Food/constituent as stated by the applicant 
According to the applicant, the food that is the subject of the health claim is Nutriose
®
06, described as 
a resistant dextrin produced from wheat or maize starch. 
Health relationship as claimed by the applicant 
According to the applicant, the consumption of foods/drinks containing Nutriose
®
06 instead of high 
glycaemic carbohydrates leads to a reduced blood glucose rise. The applicant argues that this is owing 
to the fact that only 15 % of Nutriose
®
06 is hydrolysed in the upper digestive tract while 75 % are 
fermented in the large intestine and 10 % are excreted into the faeces. This low digestibility of 
Nutriose
®
06 is claimed to lead to a lower post-prandial glycaemia when replacing available 
carbohydrates in a meal, without any disproportionate increase in post-prandial insulinaemic 
response. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: “Consumption of foods/drinks 
containing Nutriose
®
06 instead of high glycaemic carbohydrates induces a lower blood glucose rise 
after their consumption compared to high glycaemic carbohydrates-containing foods/drinks”. 
Specific conditions of use as proposed by the applicant 
According to the applicant, high-glycaemic carbohydrates in foods or drinks should be replaced by 
Nutriose
®
06 so that foods or drinks contain reduced amounts of high-glycaemic carbohydrates, in 
accordance with the Annex of Regulation (EC) No 1924/2006. The proposed target population is 
individuals from the general population wishing to reduce their post-prandial glycaemic responses. 
ASSESSMENT 
1. Characterisation of the food/constituent 
The food that is the subject of the health claim is Nutriose
®
06, which should replace “high glycaemic 
carbohydrates” in foods or beverages in order to obtain the claimed effect (i.e. reduction of post-
prandial glycaemic responses). 
Nutriose
®
06 is produced from wheat or maize starch by dry roasting under acidic conditions (i.e. 
dextrinisation). The ensuing dextrin is treated enzymatically and then purified by chromatographic 
partitioning in order to minimise the content of mono- and disaccharides. During the manufacturing 
process, linear and/or branched glycosidic bonds (i.e. α-1,2; α-1,3; β-1,2; β-1,3; β-1,4; β-1,6) are 
formed, which render dextrins resistant to digestion by salivary and pancreatic amylases. The final 
product contains about 85 % resistant dextrin with an average degree of polymerisation of 12-25, and 
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less than 0.5 % mono- and disaccharides. An overview of the manufacturing process, stability data 
and batch-to-batch variability were provided. 
Following a request for clarification, the applicant indicated that the term “high-glycaemic 
carbohydrates” refers to “any carbohydrate rapidly digested and absorbed in the small intestine which 
induces a high increase in plasma glucose level, e.g. glucose, sucrose, maltose, glucose syrup, 
maltodextrin and high digestible starches”. The Panel notes that glycaemic carbohydrates include 
sugars, oligosaccharides and polysaccharides which can be digested and absorbed in the small 
intestine and contribute to post-prandial glycaemic responses (EFSA NDA Panel, 2010). 
The Panel notes that the main characteristic of Nutriose
®
06 which contributes to the claimed effect is 
the non-digestibility of the resistant dextrin contained in Nutriose
®
06 in the small intestine, and that 
replacing digestible (glycaemic) carbohydrates by any non-digestible carbohydrate would contribute 
to the claimed effect. The applicant was requested to indicate which characteristics or properties of 
resistant dextrin in Nutriose
®
06 make it unique compared with other non-digestible carbohydrates 
(e.g. non-starch polysaccharides and resistant oligosaccharides) in relation to the claimed effect. In 
reply, the applicant stated that Nutriose
®
06 is manufactured through a “unique and patented 
manufacturing process during which transglycosylation reactions occur”. The applicant claims that 
the “unique arrangement” of the glycosidic bonds in Nutriose®06 is responsible for the low glycaemic 
and low insulinaemic response of Nutriose
®
06. The Panel notes that no evidence was provided to 
indicate that the resistant dextrin in the product was different from other non-digestible carbohydrates 
in relation to the claimed effect. 
The Panel considers that in the context of this application the main characteristic of Nutriose
®
06 
which contributes to the claimed effect (i.e. reduction of post-prandial glycaemic responses by 
replacing glycaemic carbohydrates in foods and beverages) is the non-digestibility of the resistant 
dextrin contained in Nutriose
®
06. The Panel also considers that this characteristic, which is relevant 
to the claimed effect, is not unique to resistant dextrin but is common to other non-digestible 
carbohydrates (e.g. non-starch polysaccharides and resistant oligosaccharides) because, similar to 
resistant dextrin, non-digestible carbohydrates are resistant to hydrolysis and absorption in the small 
intestine and therefore do not contribute to post-prandial glycaemia. 
This opinion applies to non-digestible carbohydrates (e.g. non-starch polysaccharides, resistant 
oligosaccharides and resistant starch; EFSA NDA Panel, 2010), which should replace glycaemic 
carbohydrates in foods or beverages in order to obtain the claimed effect. 
The Panel considers that the food constituent, non-digestible carbohydrates (including resistant 
dextrin in Nutriose
®
06), which is the subject of the health claim, and the food constituent (i.e. 
glycaemic carbohydrates) that non-digestible carbohydrates should replace in foods or beverages are 
both sufficiently characterised in relation to the claimed effect. 
2. Relevance of the claimed effect to human health 
The claimed effect proposed by the applicant relates to the reduction of post-prandial blood glucose 
responses. The target population proposed by the applicant is individuals wishing to reduce their post-
prandial glycaemic responses. 
The elevation of blood glucose concentrations after consumption of a food and/or meal, i.e. post-
prandial glycaemia, is a normal physiological response which varies in magnitude and duration, and 
which may be influenced by the chemical and physical nature of the food or meal consumed, as well 
as by individual factors (Venn and Green, 2007). Decreasing post-prandial glycaemic responses may, 
for example, be beneficial to individuals with impaired glucose tolerance, as long as post-prandial 
insulinaemic responses are not disproportionately increased. Impaired glucose tolerance is common in 
the general population of adults. 
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The Panel considers that a reduction of post-prandial glycaemic responses (as long as post-prandial 
insulinaemic responses are not disproportionately increased) might be a beneficial physiological 
effect. 
3. Scientific substantiation of the claimed effect 
The applicant performed a literature search in Medline, using the search term “Nutriose”. Randomised 
controlled trials performed with Nutriose
®
06 in healthy subjects on post-prandial glycaemia were 
considered eligible. No such published studies were identified. 
The applicant submitted six unpublished human studies (Donazzolo and Latreille-Barbier, 2000; GI 
labs, 2007; Thondre and Lightowler, 2012; Yuexin et al., 2012; Gendre, 2013; Salvi, 2013; all 
claimed as proprietary by the applicant) as being pertinent to the health claim. In these studies, the 
consumption of Nutriose
®
06 was shown to induce a significant reduction of post-prandial glycaemic 
and insulinaemic responses when compared with glucose. 
A claim on non-digestible carbohydrates and reduction of post-prandial glycaemic responses has 
already been assessed by the Panel with a favourable outcome (EFSA NDA Panel, 2014). The Panel 
took into account that consumption of non-digestible carbohydrates results in reduced post-prandial 
blood glucose (and insulinaemic) responses compared with the consumption of sugars on a weight-by-
weight basis owing to the non-digestibility in the small intestine and to a decrease in the amount of 
available carbohydrates, and that the consumption of foods/drinks in which non-digestible 
carbohydrates replaced sugars induced lower post-prandial glycaemic and insulinaemic responses 
than sugar-containing foods/drinks. 
The Panel considers that the outcome, including the proposed wording and the conditions of use, of 
the previous evaluation on the replacement of sugars with non-digestible carbohydrates applies to the 
replacement of all glycaemic carbohydrates with non-digestible carbohydrates. 
The Panel concludes that a cause and effect relationship has been established between the 
consumption of foods/beverages containing non-digestible carbohydrates and a reduction of post-
prandial glycaemic responses as compared with foods/beverages containing glycaemic carbohydrates. 
The Panel notes that non-digestible carbohydrates have a neutral taste and cannot substitute for the 
sweet taste of sugars. 
The Panel could have reached this conclusion without the human studies (Donazzolo and Latreille-
Barbier, 2000; GI labs, 2007; Thondre and Lightowler, 2012; Yuexin et al., 2012; Gendre, 2013; 
Salvi, 2013) claimed as proprietary by the applicant. 
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food constituent, non-digestible carbohydrates (including resistant dextrin in 
Nutriose
®
06), which is the subject of the health claim, and the food constituent (i.e. glycaemic 
carbohydrates) that non-digestible carbohydrates should replace in foods or beverages, are 
both sufficiently characterised in relation to the claimed effect. 
 The claimed effect proposed by the applicant relates to the reduction of post-prandial blood 
glucose responses. The target population proposed by the applicant is individuals wishing to 
reduce their post-prandial glycaemic responses. A reduction of post-prandial glycaemic 
responses might be a beneficial physiological effect. 
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 A cause and effect relationship has been established between the consumption of 
foods/beverages containing non-digestible carbohydrates and a reduction of post-prandial 
glycaemic responses as compared with foods/beverages containing glycaemic carbohydrates. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on Nutriose
®
06 and reduction of post-prandial glycaemic responses pursuant 
to Article 13(5) of Regulation (EC) No 1924/2006 (Claim serial No: 0410_IT). January 2014. 
Submitted by Roquette Italia S.P.A. 
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